TOP STORIES

• BUSINESS 650 Astellas Staffers Choose Voluntary Redundancy, Sales Force Down to 1,200
  February 3, 2022

• REGULATORY DPO Opted Not to Apply 80% Pricing Rule for Vynmac for Clinical Benefits: Minutes
  February 2, 2022

• BUSINESS Sumitomo Dainippon Expects to Get Back on Growth Track in FY2025 after Latuda’s LOE: President
  February 2, 2022

• REGULATORY Japan Finalizes Deal for Pfizer’s COVID-19 Pills, Eyes Approval by Mid-February
  February 1, 2022

• REGULATORY Japan Won’t Give 3rd-Shot Approval for Shionogi’s Jab with Booster Trial Alone
  February 1, 2022

• ORGANIZATION Japan Market Should Grow in Single-Digit Range, Not Zero Growth: PhRMA Chair
  January 31, 2022

• REGULATORY MHLW Sets Volume Thresholds for Drug Orders to Resolve Generic Shortages
  January 28, 2022

• BUSINESS Flatiron Health Joins Hands with National Cancer Center to Start Up Japan Biz
  January 27, 2022

• BUSINESS Nippon Shinyaku Snags US Commercial Rights to Capricor’s DMD Cell Therapy
  January 26, 2022

• REGULATORY PMDA to Place Top Priority on Safety Measures under Proposed Emergency Approval System: Chief Executive
  January 25, 2022

• BUSINESS Novartis Downsizing Tokyo Head Office to Cut Costs and Support Diverse Work Styles
  January 24, 2022

• REGULATORY Pfizer’s Comirnaty Bags Japan Approval for Ages 5-11; Actemra OK’ed for COVID-19
  January 21, 2022

• REGULATORY Pfizer’s Comirnaty Clears Key Panel for Ages 5-11; Actemra Set for COVID-19 Nod
  January 21, 2022

• REGULATORY Macroeconomic Indexing Lacks Perspectives to Promote Innovation, Improve Care: MHLW Bureau Chief
  January 20, 2022

• REGULATORY Re-Pricing to Hit 23 Drugs in April; Takecab, GLP-1s, Vyndaqel/Vynmac, and More
  January 19, 2022

• REGULATORY Takecab Faces 2nd “Huge-Seller” Price Slash, All GLP-1 Injectables to Get Cut Too on Market Expansion
  January 18, 2022

• COMMENTARY Significance and Challenges around Proposed Emergency Approval Scheme, Eyes on Diet Debate
  January 17, 2022

• BUSINESS Pfizer Files Oral COVID-19 Pill in Japan
  January 14, 2022

• REGULATORY Pfizer’s Comirnaty Up for PAFSC Review for Ages 5-11 on Jan. 20; Actemra to Add COVID-19 Use
  January 14, 2022

• BUSINESS Keytruda, Opdivo Neck and Neck in 2021; 6 Drugs Cross 100 Billion Yen Mark: Encise
  January 13, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 78
• 79
• 80
• 81
• 82
• 83
• 84
• 85
• 86
• …
• Next ›
• 最終 »